Loading clinical trials...
Loading clinical trials...
A Multi-Center, Prospective, Randomized, Controlled, Open-label, Parallel Study to Evaluate the Safety and Efficacy of the Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients
Conditions
Interventions
Theranova 400 dialyzer
Elisio-17H dialyzer
Locations
20
United States
DaVita Corona
Corona, California, United States
DaVita Riverside
Riverside, California, United States
DaVita Inc, Greater Hartford Nephrology
Bloomfield, Connecticut, United States
DaVita Inc., Waterbury Dialysis
Middlebury, Connecticut, United States
Dialysis Center, Inc. Albany
Albany, Georgia, United States
Dialysis Center, Inc. Boston
Boston, Massachusetts, United States
Start Date
September 29, 2017
Primary Completion Date
October 27, 2018
Completion Date
October 27, 2018
Last Updated
July 14, 2025
NCT07157397
NCT07153939
NCT07146854
NCT04163614
NCT04580420
NCT06190717
Lead Sponsor
Vantive Health LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions